CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395 | +44 (0) 20 3951 8071
info@oxonepi.com

Category: News

OXON at the The Global Clinical Trials Connect 2018 conference

Nawab Qizilbash will speak and show a selection of practical examples and case studies under the title “Trials with observational designs”

OXON will present at the EFPIA PV Expert Group

OXON will present a review and discuss lessons learned from risk minimisation evaluation studies at the EFPIA PV Expert Group

Thanks for visiting us at ISPE annual meeting – ICPE 2017

We would like to thank you for visiting our booth at ISPE 2017 ANNUAL MEETING that was held in the Palais de Congress de Montreal from August 26 to August 30.

OXON at ISPOR European Congress 2017

OXON will be presenting at the 20th Annual European Congress of ISPOR:
two poster presentations focused on Clinical Outcomes Studies

OXON AT EMA/DIA Information Day

Head of OXON, Dr Nawab Qizilbash will participate
in EMA/DIA Information Day on
Measuring the Impact on Pharmacovigilance Activities.

JOIN OXON AT ISPE ANNUAL MEETING – ICPE 2017

OXON will be presenting at the 33rd International Conference for Pharmacoepidemiology:
Two oral and five poster presentations

SMi MASTERCLASS on Practical Risk Minimisation of Drugs in Europe

OXON will be attending the ISPE Mid-Year Meeting with the theme “Ensuring Opportunities Become Reality”, held on April 1 – 4, 2017 at The Royal College of Physicians, London, United Kingdom.

OXON at 2017 ISPE Mid-year Meeting

OXON will be attending the ISPE Mid-Year Meeting with the theme “Ensuring Opportunities Become Reality”, held on April 1 – 4, 2017 at The Royal College of Physicians, London, United Kingdom.

OXON at the 12th Pharmacovigilance 2017 Conference

22nd – 23rd February 2017, Pestana Chelsea Bridge Hotel, London UK
Nawab Qizilbash, Head of OXON, will be presenting “Post marketing drug surveillance”

""

Presentation on “Measuring the impact of pharmacovigilance activities” at the EMA workshop

The European Medicines Agency (EMA) has published the list of participants and the presentations of the different speakers of the workshop “Measuring the impact of pharmacovigilance activities”